Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006692
Filing Date
2025-03-04
Accepted
2025-03-04 18:33:16
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 form4-03042025_110312.html 4  
1 form4-03042025_110312.xml 4 4026
  Complete submission text file 0001415889-25-006692.txt   5562
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Hung David (Reporting) CIK: 0001310880 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 25707336

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)